Locations:
Search IconSearch

Heart, Vascular and Thoracic

HeartMate 3 Device

Next-Gen LVAD Trial Highlights Evolving View of Device Use

Distinction between bridge and destination therapy is fading

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Diabetes Doesn’t Influence Long-Term Graft Patency After Heart Bypass Surgery

Diabetes Doesn’t Influence Long-Term Graft Patency After Heart Bypass

Other factors explain diabetic patients’ poorer outcomes after bypass

690×380-Mehra

Patient Preference Should Guide Postoperative AF Strategy

No clinical advantage to either rhythm or rate control

178489842_650x450

GAUSS-3 Yields Robust Evidence of Muscle-Related Statin Intolerance

Also finds PCSK9 inhibitor more potent than ezetimibe in statin-intolerant patients

BackPage 87 of 108Next

Advertisement

Ad